For citations:
Vasilyeva E.B., Rostovtsev D.M., Tolpeikina К.A., Fatkullin D.M., Guz A.О. Clinical experience in the neoadjuvant treatment of unresectable differentiated thyroid cancer with the lenvatinib. Head and Neck Tumors (HNT). 2024;14(1):10-15. (In Russ.) https://doi.org/10.17650/2222-1468-2024-14-1-10-15
Email this article 